Financials
- Market Capitalization 7.96 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1022 | IBRX ImmunityBio, Inc. - Common Stock | 7.88 USD | +1.16% | -9.43% | +10.67% | +184.48% | 8.25 B USD | ||
| 1032 | PCVX Vaxcyte, Inc. - Common Stock | 56.21 USD | -1.44% | -6.33% | +13.40% | +32.88% | 8.12 B USD | ||
| 1057 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 61.98 USD | +1.71% | -7.80% | +18.74% | +56.34% | 7.75 B USD | ||
| 1072 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 109.96 USD | +2.30% | -2.47% | +20.91% | -0.32% | 7.54 B USD |